JOSH'S STORY
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreALL is the commonest cancer of childhood and treatment related toxicity and relapse are important therapeutic challenges. To further improve outcome new, non-toxic, targeted therapies need to be developed. These may be targeted to the leukaemic population in general or to the sub-population thought to give rise to relapse. Relapsed disease is characterised by an increased involvement of sites other than the bone marrow. This has led to the suggestion that chemo-resistance and invasion may be linked.
Grant Award – Kidscan PhD Studentship (2012 – 2015)
Funding Award – £65,000.00
Funding Awarded to – Professor Vaskar Saha
Research Location – University of Manchester
Lead Researcher – Professor Vaskar Saha
In February of 2021, Josh’s parents noticed he was getting very pale. What was originally thought to...
Read MoreWhat a whopper of a night - Friday 20th May, our ambassador Isla's mum Jill and family hosted...
Read MoreWe want to say a huge thank you to Lee Mossop, former Captain of RFL Salford Red...
Read More